Cargando…

The Effect of ß-Glucan Prebiotic on Kidney Function, Uremic Toxins and Gut Microbiome in Stage 3 to 5 Chronic Kidney Disease (CKD) Predialysis Participants: A Randomized Controlled Trial

There is growing evidence that gut dysbiosis contributes to the progression of chronic kidney disease (CKD) owing to several mechanisms, including microbiota-derived uremic toxins, diet and immune-mediated factors. The aim of this study was to investigate the effect of a ß-glucan prebiotic on kidney...

Descripción completa

Detalles Bibliográficos
Autores principales: Ebrahim, Zarina, Proost, Sebastian, Tito, Raul Yhossef, Raes, Jeroen, Glorieux, Griet, Moosa, Mohammed Rafique, Blaauw, Renée
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8880761/
https://www.ncbi.nlm.nih.gov/pubmed/35215453
http://dx.doi.org/10.3390/nu14040805
_version_ 1784659300889657344
author Ebrahim, Zarina
Proost, Sebastian
Tito, Raul Yhossef
Raes, Jeroen
Glorieux, Griet
Moosa, Mohammed Rafique
Blaauw, Renée
author_facet Ebrahim, Zarina
Proost, Sebastian
Tito, Raul Yhossef
Raes, Jeroen
Glorieux, Griet
Moosa, Mohammed Rafique
Blaauw, Renée
author_sort Ebrahim, Zarina
collection PubMed
description There is growing evidence that gut dysbiosis contributes to the progression of chronic kidney disease (CKD) owing to several mechanisms, including microbiota-derived uremic toxins, diet and immune-mediated factors. The aim of this study was to investigate the effect of a ß-glucan prebiotic on kidney function, uremic toxins and the gut microbiome in stage 3 to 5 CKD participants. Fifty-nine participants were randomized to either the ß-glucan prebiotic intervention group (n = 30) or the control group (n = 29). The primary outcomes were to assess kidney function (urea, creatinine and glomerular filtration rate), plasma levels of total and free levels of uremic toxins (p-cresyl sulfate (pCS), indoxyl-sulfate (IxS), p-cresyl glucuronide (pCG) and indoxyl 3-acetic acid (IAA) and gut microbiota using 16S rRNA sequencing at baseline, week 8 and week 14. The intervention group (age 40.6 ± 11.4 y) and the control group (age 41.3 ± 12.0 y) did not differ in age or any other socio-demographic variables at baseline. There were no significant changes in kidney function over 14 weeks. There was a significant reduction in uremic toxin levels at different time points, in free IxS at 8 weeks (p = 0.003) and 14 weeks (p < 0.001), free pCS (p = 0.006) at 14 weeks and total and free pCG (p < 0.001, p < 0.001, respectively) and at 14 weeks. There were no differences in relative abundances of genera between groups. Enterotyping revealed that the population consisted of only two of the four enterotypes: Bacteroides 2 and Prevotella. The redundancy analysis showed a few factors significantly affected the gut microbiome: these included triglyceride levels (p < 0.001), body mass index (p = 0.002), high- density lipoprotein (p < 0.001) and the prebiotic intervention (p = 0.002). The ß-glucan prebiotic significantly altered uremic toxin levels of intestinal origin and favorably affected the gut microbiome.
format Online
Article
Text
id pubmed-8880761
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-88807612022-02-26 The Effect of ß-Glucan Prebiotic on Kidney Function, Uremic Toxins and Gut Microbiome in Stage 3 to 5 Chronic Kidney Disease (CKD) Predialysis Participants: A Randomized Controlled Trial Ebrahim, Zarina Proost, Sebastian Tito, Raul Yhossef Raes, Jeroen Glorieux, Griet Moosa, Mohammed Rafique Blaauw, Renée Nutrients Article There is growing evidence that gut dysbiosis contributes to the progression of chronic kidney disease (CKD) owing to several mechanisms, including microbiota-derived uremic toxins, diet and immune-mediated factors. The aim of this study was to investigate the effect of a ß-glucan prebiotic on kidney function, uremic toxins and the gut microbiome in stage 3 to 5 CKD participants. Fifty-nine participants were randomized to either the ß-glucan prebiotic intervention group (n = 30) or the control group (n = 29). The primary outcomes were to assess kidney function (urea, creatinine and glomerular filtration rate), plasma levels of total and free levels of uremic toxins (p-cresyl sulfate (pCS), indoxyl-sulfate (IxS), p-cresyl glucuronide (pCG) and indoxyl 3-acetic acid (IAA) and gut microbiota using 16S rRNA sequencing at baseline, week 8 and week 14. The intervention group (age 40.6 ± 11.4 y) and the control group (age 41.3 ± 12.0 y) did not differ in age or any other socio-demographic variables at baseline. There were no significant changes in kidney function over 14 weeks. There was a significant reduction in uremic toxin levels at different time points, in free IxS at 8 weeks (p = 0.003) and 14 weeks (p < 0.001), free pCS (p = 0.006) at 14 weeks and total and free pCG (p < 0.001, p < 0.001, respectively) and at 14 weeks. There were no differences in relative abundances of genera between groups. Enterotyping revealed that the population consisted of only two of the four enterotypes: Bacteroides 2 and Prevotella. The redundancy analysis showed a few factors significantly affected the gut microbiome: these included triglyceride levels (p < 0.001), body mass index (p = 0.002), high- density lipoprotein (p < 0.001) and the prebiotic intervention (p = 0.002). The ß-glucan prebiotic significantly altered uremic toxin levels of intestinal origin and favorably affected the gut microbiome. MDPI 2022-02-14 /pmc/articles/PMC8880761/ /pubmed/35215453 http://dx.doi.org/10.3390/nu14040805 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Ebrahim, Zarina
Proost, Sebastian
Tito, Raul Yhossef
Raes, Jeroen
Glorieux, Griet
Moosa, Mohammed Rafique
Blaauw, Renée
The Effect of ß-Glucan Prebiotic on Kidney Function, Uremic Toxins and Gut Microbiome in Stage 3 to 5 Chronic Kidney Disease (CKD) Predialysis Participants: A Randomized Controlled Trial
title The Effect of ß-Glucan Prebiotic on Kidney Function, Uremic Toxins and Gut Microbiome in Stage 3 to 5 Chronic Kidney Disease (CKD) Predialysis Participants: A Randomized Controlled Trial
title_full The Effect of ß-Glucan Prebiotic on Kidney Function, Uremic Toxins and Gut Microbiome in Stage 3 to 5 Chronic Kidney Disease (CKD) Predialysis Participants: A Randomized Controlled Trial
title_fullStr The Effect of ß-Glucan Prebiotic on Kidney Function, Uremic Toxins and Gut Microbiome in Stage 3 to 5 Chronic Kidney Disease (CKD) Predialysis Participants: A Randomized Controlled Trial
title_full_unstemmed The Effect of ß-Glucan Prebiotic on Kidney Function, Uremic Toxins and Gut Microbiome in Stage 3 to 5 Chronic Kidney Disease (CKD) Predialysis Participants: A Randomized Controlled Trial
title_short The Effect of ß-Glucan Prebiotic on Kidney Function, Uremic Toxins and Gut Microbiome in Stage 3 to 5 Chronic Kidney Disease (CKD) Predialysis Participants: A Randomized Controlled Trial
title_sort effect of ß-glucan prebiotic on kidney function, uremic toxins and gut microbiome in stage 3 to 5 chronic kidney disease (ckd) predialysis participants: a randomized controlled trial
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8880761/
https://www.ncbi.nlm.nih.gov/pubmed/35215453
http://dx.doi.org/10.3390/nu14040805
work_keys_str_mv AT ebrahimzarina theeffectofßglucanprebioticonkidneyfunctionuremictoxinsandgutmicrobiomeinstage3to5chronickidneydiseaseckdpredialysisparticipantsarandomizedcontrolledtrial
AT proostsebastian theeffectofßglucanprebioticonkidneyfunctionuremictoxinsandgutmicrobiomeinstage3to5chronickidneydiseaseckdpredialysisparticipantsarandomizedcontrolledtrial
AT titoraulyhossef theeffectofßglucanprebioticonkidneyfunctionuremictoxinsandgutmicrobiomeinstage3to5chronickidneydiseaseckdpredialysisparticipantsarandomizedcontrolledtrial
AT raesjeroen theeffectofßglucanprebioticonkidneyfunctionuremictoxinsandgutmicrobiomeinstage3to5chronickidneydiseaseckdpredialysisparticipantsarandomizedcontrolledtrial
AT glorieuxgriet theeffectofßglucanprebioticonkidneyfunctionuremictoxinsandgutmicrobiomeinstage3to5chronickidneydiseaseckdpredialysisparticipantsarandomizedcontrolledtrial
AT moosamohammedrafique theeffectofßglucanprebioticonkidneyfunctionuremictoxinsandgutmicrobiomeinstage3to5chronickidneydiseaseckdpredialysisparticipantsarandomizedcontrolledtrial
AT blaauwrenee theeffectofßglucanprebioticonkidneyfunctionuremictoxinsandgutmicrobiomeinstage3to5chronickidneydiseaseckdpredialysisparticipantsarandomizedcontrolledtrial
AT ebrahimzarina effectofßglucanprebioticonkidneyfunctionuremictoxinsandgutmicrobiomeinstage3to5chronickidneydiseaseckdpredialysisparticipantsarandomizedcontrolledtrial
AT proostsebastian effectofßglucanprebioticonkidneyfunctionuremictoxinsandgutmicrobiomeinstage3to5chronickidneydiseaseckdpredialysisparticipantsarandomizedcontrolledtrial
AT titoraulyhossef effectofßglucanprebioticonkidneyfunctionuremictoxinsandgutmicrobiomeinstage3to5chronickidneydiseaseckdpredialysisparticipantsarandomizedcontrolledtrial
AT raesjeroen effectofßglucanprebioticonkidneyfunctionuremictoxinsandgutmicrobiomeinstage3to5chronickidneydiseaseckdpredialysisparticipantsarandomizedcontrolledtrial
AT glorieuxgriet effectofßglucanprebioticonkidneyfunctionuremictoxinsandgutmicrobiomeinstage3to5chronickidneydiseaseckdpredialysisparticipantsarandomizedcontrolledtrial
AT moosamohammedrafique effectofßglucanprebioticonkidneyfunctionuremictoxinsandgutmicrobiomeinstage3to5chronickidneydiseaseckdpredialysisparticipantsarandomizedcontrolledtrial
AT blaauwrenee effectofßglucanprebioticonkidneyfunctionuremictoxinsandgutmicrobiomeinstage3to5chronickidneydiseaseckdpredialysisparticipantsarandomizedcontrolledtrial